Comparison of the Quadratus Lumborum Block With the Transversus Abdominis Plan Block
Comparison of Quadratus Lumborum Block and Transversus Abdominis Plane Block for Postoperative Pain Control After Laparoscopic Cholecystectomy
1 other identifier
interventional
60
1 country
1
Brief Summary
In this study, investigators aimed to compare the Quadratus Lumborum Block and the Transversus Abdominis Plan Block for postoperative pain control after laparoscopic cholecystectomy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Apr 2017
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2017
CompletedFirst Posted
Study publicly available on registry
April 13, 2017
CompletedStudy Start
First participant enrolled
April 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2018
CompletedSeptember 26, 2017
September 1, 2017
1.3 years
February 27, 2017
September 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total cumulative morphine consumption
Total cumulative morphine dose in mg used in the first 24 hours after surgery
24 hour
Secondary Outcomes (2)
Severity of postoperative pain via visual analogue pain scale (VAS)
24 hour
Nausea or vomiting
24 hour
Study Arms (2)
QLB: Quadratus lumborum block
ACTIVE COMPARATORQLB: Quadratus lumborum block :Quadratus Lumborum block group (QL) patients will receive a bilateral Quadratus Lumborum block using Bupivicaine 0.25 %
TAP: transversus abdominis plan block
ACTIVE COMPARATORTAP: Transversus abdominis plane block (TAP) patients will receive a bilateral TAP block using Bupivicaine 0.25%
Interventions
QLB: Quadratus lumborum block : 20 mL of 0.25% bupivacaine will be administered between the quadratus lumborum and the psoas major muscle bilaterally in the lateral decubitus position
TAP: transversus abdominis plan block: 20 mL of 0.25% bupivacaine will be administered between the internal oblique muscle and the transversus abdominis muscle bilaterally in the supine position
Eligibility Criteria
You may qualify if:
- ASA 1-2-3
- elective Laparoscopic cholecystectomy
- years
- Written informed consent
You may not qualify if:
- Patient refusal Local infection at the site of injection
- Allergy to study medications Sepsis Anatomic abnormalities Systemic anticoagulation or coagulopathy - Inability to comprehend or participate in pain scoring system
- Inability to use intravenous patient controlled analgesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kecioren ETH
Ankara, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Double-blind randomized controlled trail
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant doctor
Study Record Dates
First Submitted
February 27, 2017
First Posted
April 13, 2017
Study Start
April 20, 2017
Primary Completion
August 1, 2018
Study Completion
September 12, 2018
Last Updated
September 26, 2017
Record last verified: 2017-09